PPARG and atherosclerosis: PPAR-γ agonists have been shown to stabilize atherogenic plaques and attenuate the risk of rupture by inhibiting foam cell formation and smooth muscle cell migration, which have a pivotal role in atherosclerosis progression [37,38,39].